Posted in | News

REpower Wins Order from National Wind for 20 MM92 Wind Turbines

REpower Systems AG (WKN 617703) has received a contract from National Wind LLC, America’s leading large-scale community wind project developer, to supply 20 MM92 wind turbines. The MM92 type turbines have a rated power of 2.05 MW (megawatts) and a hub height of 100 meters. The turbines will be used in the first phase of the Lake Country Wind Energy project in central Minnesota. All phases of the project will total 340 MW.

Following the successful construction of projects in Washington, Oregon, Indiana, Michigan and California, these are the first wind turbines that the US subsidiary of Hamburg-based REpower Systems AG will deliver to Minnesota. “The US market is gradually starting to recover,” says Per Hornung Pedersen, CEO of REpower Systems AG. “This order and the other signed contracts in the last few months show that our North American business is slowly picking up again.”

Steve Dayney, CEO of REpower USA Corp., adds: “We are pleased to be collaborating with National Wind for the first time and to be entering a new state with the Lake Country project. Minnesota is one of the fastest-growing US states for the wind business, which makes it an important and promising region for us.”

“We strongly value our new relationship with REpower and look forward to building upon it,” says Jack Levi, co-chair of National Wind. “Securing wind turbines is a significant project milestone for Lake Country Wind Energy. Not only is REpower’s turbine technology an ideal fit for the project’s wind regime, it also advances Lake Country’s first phase toward a late 2010 construction. It is exciting to bring Meeker and Kandiyohi Counties’ first utility-scale community-owned wind project closer to reality.”

Source: http://www.repower.de/index.php?L=1

Tell Us What You Think

Do you have a review, update or anything you would like to add to this news story?

Leave your feedback
Your comment type
Submit

While we only use edited and approved content for Azthena answers, it may on occasions provide incorrect responses. Please confirm any data provided with the related suppliers or authors. We do not provide medical advice, if you search for medical information you must always consult a medical professional before acting on any information provided.

Your questions, but not your email details will be shared with OpenAI and retained for 30 days in accordance with their privacy principles.

Please do not ask questions that use sensitive or confidential information.

Read the full Terms & Conditions.